I agree that this site is using cookies. You can find further informations here.
X
Zenke, Yoshitaka
54  results:
Search for persons X
?
1

Prognostic value of predominant subtype in pathological sta..:

Kitagawa, Shingo ; Zenke, Yoshitaka ; Taki, Tetsuro...
Lung Cancer.  188 (2024)  - p. 107453 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Phase 1 study of pembrolizumab plus chemotherapy in Japanes..:

Nogami, Naoyuki ; Tokito, Takaaki ; Zenke, Yoshitaka...
Investigational New Drugs.  42 (2024)  1 - p. 136-144 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Clinical outcomes in patients with non-small cell lung canc..:

Okahisa, Masanobu ; Udagawa, Hibiki ; Matsumoto, Shingo...
Lung Cancer.  191 (2024)  - p. 107798 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Pharmacokinetic and dose‐finding study of osimertinib in pa..:

Fujiwara, Yutaka ; Makihara, Reiko ; Hase, Tetsunari...
Cancer Science.  114 (2023)  5 - p. 2087-2097 , 2023
Link: https://doi.org/10.1111/..
 
?
5

Prognostic impact and gene expression analysis of peri‐tumo..:

Kagawa, Yosuke ; Nakai, Tokiko ; Taki, Tetsuro...
Cancer Science.  114 (2023)  8 - p. 3423-3432 , 2023
Link: https://doi.org/10.1111/..
 
?
6

Clinicopathological significance of peritumoral alveolar ma..:

Tanaka, Yu ; Nakai, Tokiko ; Suzuki, Ayako...
Cancer Immunology, Immunotherapy.  72 (2023)  7 - p. 2205-2215 , 2023
Link: https://doi.org/10.1007/..
 
?
7

Large-scale clinico-genomic profile of non-small cell lung ..:

Tamiya, Yutaro ; Matsumoto, Shingo ; Zenke, Yoshitaka...
Lung Cancer.  176 (2023)  - p. 103-111 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Efficacy and safety of second-line therapy of docetaxel plu..:

Matsuzawa, Reiko ; Morise, Masahiro ; Ito, Kentaro...
eClinicalMedicine.  66 (2023)  - p. 102303 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Study Design and Rationale for Marble Study: A Phase II Tri..:

Asao, Tetsuhiko ; Shukuya, Takehito ; Mimori, Tomoyasu...
Clinical Lung Cancer.  24 (2023)  7 - p. e247-e253 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Clinicogenomic Features and Targetable Mutations in NSCLCs ..:

Sakai, Tetsuya ; Matsumoto, Shingo ; Ueda, Yasuto...
Journal of Thoracic Oncology.  18 (2023)  11 - p. 1538-1549 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Prognostic impact of EGFR/ALK alterations in leptomeningeal..:

Oyoshi, Hidekazu ; Hirata, Hidenari ; Hirano, Yasuhiro...
Clinical & Experimental Metastasis.  40 (2023)  5 - p. 407-413 , 2023
Link: https://doi.org/10.1007/..
 
?
12

Study protocol for JCOG1807C (DEEP OCEAN): a interventional..:

Aokage, Keiju ; Tsuboi, Masahiro ; Zenke, Yoshitaka...
Japanese Journal of Clinical Oncology.  52 (2022)  4 - p. 383-387 , 2022
Link: https://doi.org/10.1093/..
 
?
13

The impact of tertiary lymphoid structures on clinicopathol..:

Tamiya, Yutaro ; Nakai, Tokiko ; Suzuki, Ayako...
Lung Cancer.  174 (2022)  - p. 125-132 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Trastuzumab emtansine for patients with non–small cell lung..:

Iwama, Eiji ; Zenke, Yoshitaka ; Sugawara, Shunichi...
European Journal of Cancer.  162 (2022)  - p. 99-106 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Medical management of older patients with lung cancer:

Zenke, Yoshitaka ; Hakozaki, Taiki ; Nakahara, Yoshiro...
Japanese Journal of Clinical Oncology.  , 2022
Link: https://doi.org/10.1093/..
 
1-15